Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiron lowers Fluvirin production estimate

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

Chiron will produce 18 mil. to 20 mil. doses of its influenza vaccine Fluvirin for the 2005-06 flu season, the company says June 15. The firm previously projected its production level would be 25 mil. to 30 mil. doses (1Pharmaceutical Approvals Monthly June 2005, In Brief). Chiron expects FDA to inspect its manufacturing facility this month to determine whether deficiencies noted in a December 2004 warning letter have been resolved. GlaxoSmithKline plans to provide 10 mil. doses of its flu vaccine Fluarix for the 2005-06 season; the firm submitted the Fluarix BLA May 25...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS002953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel